Eliem Therapeutics, Inc. (ELYM)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

1

0

3

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
01-Jul-24 9:29 PM View:	27-Jun-24 Purchase $49.95M	Ra Capital Management, LLC Director 10% Owner		Eliem Therapeutics, Inc. - ELYM	139% 13.15M to 31.42M	0	0	--	--	Show Txns Hide Txns

23-Jul-24 5:04 PM View:	22-Jul-24 Sale ($554.17K)	Morisset Valerie EVP, R&D and CSO		Eliem Therapeutics, Inc. - ELYM	(94%) 487.46K to 31.32K	0	0	--	--	Show Txns Hide Txns

21-Jun-24 2:57 PM View:	20-Jun-24 Option Sale ($8.98K)	Pimblett Emily Chief Accounting Officer		Eliem Therapeutics, Inc. - ELYM	100% 0 to 3.75K	0	0	--	--	Show Txns Hide Txns

27-Jun-24 7:03 PM View:	27-Jun-24 Grant 0	Thomas Stephen Basil Director		Eliem Therapeutics, Inc. - ELYM	100% 0 to 103.91K	0	0	--	--	Show Txns Hide Txns